Heidelberg, Germany, August 5, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate […]
Second quarter total revenue of $91.9 million, up 125% year-over-yearOver 410,000 enrolled Livongo for Diabetes Members, up 113% year-over-yearMOUNTAIN VIEW, […]